Navigation Links
K-V Pharmaceutical Secures Financing Commitments Establishing Path Forward For Specialty Pharmaceutical Business
Date:11/17/2010

rough all federal and state healthcare programs.    

In addition, in a separate Divestiture Agreement with HHS OIG, the Company agreed to dissolve ETHEX Corporation (a wholly-owned subsidiary) under Missouri law, and dispose of its remaining assets and resolve its liabilities consistent with Missouri law.   As previously reported, ETHEX was at risk of exclusion by HHS OIG.  In exchange for the dissolution of ETHEX and the disposal of its remaining assets by April 28, 2011, and its liabilities over the additional period of time provided by Missouri law, HHS OIG agreed not to exclude ETHEX.      

As a result of Mr. Hermelin’s resignation and the two agreements with HHS OIG, the Company believes it has resolved its remaining issues with respect to HHS OIG and is positioned to continue to participate in Federal health care programs now and in the future.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a fully-integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology-distinguished branded prescription products.  The Company markets its technology-distinguished products through Ther-Rx Corporation, its branded drug subsidiary.

For further information about K-V Pharmaceutical Company, please visit the Company's website at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

This press releases contains various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 (the "PSLRA") and that may be based on or include assumptions concerning the operations, future results and prospects of the Registrant. Such statements may be identified by the use of words like "pl
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013 ... China Pharmaceutical Guidebook: Latest Chinese Regulations ... ).      (Logo: http://photos.prnewswire.com/prnh/20130128/590935) ... possesses a fourth population in ... the largest drug markets round the ...
(Date:6/17/2013)... --  Southern Research Institute today announced that ... its Board of Directors to serve as president and ... (Photo: http://photos.prnewswire.com/prnh/20130617/DC33167 ) ... served as president and CEO of Southern Research Institute ... year after 34 years of service at Southern Research. ...
(Date:6/17/2013)... SYDNEY , June 17, 2013 ... ASX: HIN), a leading innovator of less invasive, ... treatment of advanced heart failure, today announced that ... granted conditional approval to an IDE (Investigational Device ... in an additional patient cohort for ENDURANCE, the ...
Breaking Medicine Technology:China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 2China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 3China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration 4Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 2Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 2HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 3HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial 4
... NOTTINGHAM, England, January 23, 2012 BACDT and ... on his way to Uganda to help set up a ... Christian Relief Uganda. The trip has been arranged ... time the charities have worked with a Clinical Dental Technician ...
... Calif., Jan. 23, 2012 ThermoGenesis Corp. (NASDAQ: ... that process and store adult stem cells, said today, it ... System from a new public cord blood bank that will ... Blood Services, a national charitable organization that manages the supply ...
Cached Medicine Technology:BACDT Member Mark Melbourne off to Uganda With Dentaid and Christian Relief 2Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 2Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 3Canada's First National Public Cord Blood Bank Adopts ThermoGenesis BioArchive Cryopreservation System 4
(Date:6/17/2013)... The Professional Center for Enhanced Performance ... open in Schertz. The center will offer ... to educational support groups. , Neurofeedback treatment is ... with athletic performance, post traumatic stress disorder, and ... LCSW, works primarily with those affected by military ...
(Date:6/17/2013)... cancer treatment often lose their fertility because chemotherapy ... ovarian eggs, called oocytes. Now, Northwestern Medicine scientists ... the death of immature ovarian eggs due to ... Scientists achieved this in female mice by adding ... another chemotherapy drug cisplatin. , The results will ...
(Date:6/17/2013)... Each year, millions of patients seek treatment for vein ... Specialists in Winston-Salem, NC is spreading the word about new ... safer and more effective. , Vein treatment has come ... patients may think they know from past experience could well ... off diseased veins permanently, allowing them to be gradually reabsorbed ...
(Date:6/17/2013)... Reliable services of Link to Pay have been offered ... that can fix payment processing. , Schools and colleges have ... Collecting fees from students and processing them may be a ... such cases, colleges and universities are looking for some smart ... out efficiently without any complications. , At the same time, ...
(Date:6/17/2013)... are more likely than their normal-weight counterparts to ... new study. Findings showed that obese adolescents had ... almost twice as likely to have unilateral (one-sided) ... by The Laryngoscope , a journal published ... , "This is the first paper to ...
Breaking Medicine News(10 mins):Health News:Professional Center for Enhanced Performance Opens in Schertz 2Health News:Preventing eggs' death from chemotherapy 2Health News:Novant Health & Vein Specialists Educates Public About Safer, More Advanced Vein Treatments through Social Media Efforts 2Health News:PayCanada Offers Link to Pay Services to its Customers 2Health News:Obesity associated with hearing loss in adolescents 2Health News:Obesity associated with hearing loss in adolescents 3
... of Entries Available Through Charities and Tour Groups, ... announced today that,registration for the Bank of America ... on to complete the 26.2-mile race, marking the ... still available,through affiliated charities and tour groups., ...
... HILL, N.C., April 23 Global leaders are,rediscovering ... a powerful tool for competing in today,s economic,environment, ... Best Practices, LLC.,The study further reveals -- Competitive ... process of transforming raw competitive data,into actionable insights ...
... people with these headaches suffer from skin discomfort, study ... who have migraines -- either chronic or episodic -- ... and sensitivity, new research shows. , As many as ... a condition called cutaneous allodynia. Cutaneous allodynia is skin ...
... who care for older adults need our support.,The pressure ... With little free time and few resources, caregivers are ... April 23 In addition to their,primary jobs in ... taking,on the additional role of caregiver to others., ...
... and Industry Directions Launch New Study, FALLS ... and Industry Directions Inc., in close,association with research ... to respond to a new survey on current ... objectives,business processes and practices, information systems and applications, ...
... 23 Perrigo Company,(Nasdaq: PRGO ; TASE) today ... quarter fiscal 2008 on Tuesday, May 6, 2008 at ... call at 10:00 a.m.,(ET) hosted by Joseph C. Papa, ... will be available live via webcast to interested,parties on ...
Cached Medicine News:Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2Health News:Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines 2Health News:Skin Pain, Sensitivity Rises With Migraine 2Health News:Skin Pain, Sensitivity Rises With Migraine 3Health News:'2008 Caregiving Conferences' Come to Wayne County, Offering Free Workshops and Resources in Canton and Taylor Locations 2Health News:Risk Management: Best Practices for Medical Device Profitability 2
... InSync Sentry cardiac resynchronization therapy (CRT) ... implantable medical therapy offering automatic fluid status ... area encompassing the lungs and heart. This ... advantage in managing heart failure, since thoracic ...
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... needs of its users for onboard data management ... latest development in its haematology analyser range, the ... new features, the PENTRA XL 80 incorporates all ... fully automated throughput of 80 samples per hour ...
Medicine Products: